(Q34153679)

English

Phase 1 first-in-human trial of the vascular disrupting agent plinabulin(NPI-2358) in patients with solid tumors or lymphomas

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

Phase 1 first-in-human trial of the vascular disrupting agent plinabulin(NPI-2358) in patients with solid tumors or lymphomas (English)
Kyriakos P Papadopoulos
Saskia T C Neuteboom

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit